Thrivent Financial For Lutherans Seagen Inc. Transaction History

Thrivent Financial For Lutherans

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $440,020 - $521,748	3,749 New	3,749 $482,000
Q2 2022 Aug 16, 2022	SELL	$108.81 - $179.33 $964,818 - $1.59 Million	-8,867 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $1.06 Million - $1.4 Million	8,867 New	8,867 $1.28 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $894,777 - $1.24 Million	-6,507 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $1.07 Million - $1.38 Million	6,507 New	6,507 $1.14 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.